| Name | Tinlorafenib |
|---|
| Description | Tinlorafenib (PF-07284890) (compound 10) is an orally active BRAF kinase inhibitor, with IC50s of 4.25 and 2.7 nM for BRAFV600E/V600K respectively. Tinlorafenib demonstrates CNS penetration and can be used in the research of BRAF-associated malignant and benign tumors of the CNS as well as extracranial malignancies[1]. |
|---|---|
| Related Catalog | |
| Target |
BRafV600E:4.25 nM (IC50) BRafV600K:2.7 nM (IC50) |
| References |
| Molecular Formula | C19H19ClF2N4O3S |
|---|---|
| Molecular Weight | 456.89 |